Brief: GT Biopharma Announces Sale Of Its Fixed Dose Combination Tablet (Gtb-004) For Myasthenia Gravis (Chronic Autoimmune Disease) To Das Therapeutics
24/09/2019 12:36
Sept 24 (Reuters) - GT Biopharma Inc GTBP.PK :
* PRESS RELEASE - GT BIOPHARMA ANNOUNCES THE SALE OF ITS
FIXED
DOSE COMBINATION TABLET (GTB-004) FOR MYASTHENIA GRAVIS (CHRONIC
AUTOIMMUNE DISEASE) TO DAS THERAPEUTICS
* GT BIOPHARMA - TO RECEIVE $200,000 UP-FRONT PAYMENT,
ANNUAL
ROYALTIES OF 1.5% OF NET YEARLY SALES, $6 MILLION PAYMENT BASED
ON COMMERCIAL MILESTONE
Source text for Eikon: ID:nCNWnfzzla
Further company coverage: GTBP.PK
((Reuters.Briefs@thomsonreuters.com;))